Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Literature DB >> 30363842

Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Deborah A Hall¹, Maria João Forjaz², Lawrence I Golbe³, Irene Litvan⁴, Christine Ann M Payan⁵, Christopher G Goetz¹, Albert F G Leentjens⁶, Pablo Martinez-Martin⁷, Anne Pavy-Le Traon⁸, Cristina Sampaio⁹, Bart Post¹⁰, Glenn Stebbins¹, Daniel Weintraub¹¹, Anette Schrag¹².

Abstract

Entities: Disease

Keywords: progressive supranuclear palsy; rating scale

Year: 2015 PMID： 30363842 PMCID： PMC6183172 DOI： 10.1002/mdc3.12130

Source DB: PubMed Journal: Mov Disord Clin Pract ISSN： 2330-1619

× No keyword cloud information.

57 in total

1. PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors: J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal: Arch Neurol Date: 1964-04

2. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors: Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal: Mov Disord Date: 2004-09 Impact factor: 10.338

Review 3. Extrapyramidal syndromes in frontotemporal degeneration.

Authors: Andrew Kertesz; Paul McMonagle; Sarah Jesso
Journal: J Mol Neurosci Date: 2011-09-02 Impact factor: 3.444

4. Parkinsonism: onset, progression and mortality.

Authors: M M Hoehn; M D Yahr
Journal: Neurology Date: 1967-05 Impact factor: 9.910

Review 5. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors: J L Cummings
Journal: Neurology Date: 1997-05 Impact factor: 9.910

6. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors: J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal: Neurology Date: 1994-12 Impact factor: 9.910

7. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].

Authors: N Hirono; H Kobayashi; E Mori
Journal: No To Shinkei Date: 1998-06

8. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.

Authors: Friederike Sixel-Döring; Marcus Schweitzer; Brit Mollenhauer; Claudia Trenkwalder
Journal: Sleep Med Date: 2008-10-21 Impact factor: 3.492

Review 9. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.

Authors: Carlo Colosimo; Pablo Martínez-Martín; Giovanni Fabbrini; Robert A Hauser; Marcelo Merello; Janis Miyasaki; Werner Poewe; Cristina Sampaio; Olivier Rascol; Glenn T Stebbins; Anette Schrag; Christopher G Goetz
Journal: Mov Disord Date: 2010-07-15 Impact factor: 10.338

Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

1. PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

2. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Review 3. Extrapyramidal syndromes in frontotemporal degeneration.

4. Parkinsonism: onset, progression and mortality.

Review 5. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

6. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

7. [Caregiver burden in dementia: evaluation with a Japanese version of the Zarit caregiver burden interview].

8. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.

Review 9. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.

10. Can the 'head-turning sign' be a clinical marker of Alzheimer's disease?

1. Laboratory based assessment of gait and balance impairment in patients with progressive supranuclear palsy.

2. Association of Progressive Supranuclear Palsy Rating Scale with Progressive Supranuclear Palsy Quality of Life Scale.

3. Exercise and physical activity for people with Progressive Supranuclear Palsy: a systematic review.

4. Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study.

Review 5. Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles.